TCM
CRL icon

Tradewinds Capital Management’s Charles River Laboratories CRL Stock Holding History

Tradewinds Capital Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-57
Closed -$3K – 623
2014
Q3 		$3K Hold
57
– – ﹤0.01% 480
2014
Q2 		$3K Hold
57
– – ﹤0.01% 495
2014
Q1 		$3K Hold
57
– – ﹤0.01% 501
2013
Q4 		$3K Buy
+57
New +$2.86K ﹤0.01% 487

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
FC
Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Tradewinds Capital Management's CRL Position: Q4 2014 in Review

Tradewinds Capital Management sold out of Charles River Laboratories (CRL) in Q4 2014, closing a stake of 57 shares — an estimated $3K sold.

Tradewinds Capital Management first reported a position in CRL in Q4 2013 and held it in 4 quarters. The position peaked at $3K in Q3 2014. 252 funds tracked by Wall St. Rank hold CRL as of Q4 2014.

  • Tradewinds Capital Management reported no remaining Charles River Laboratories position as of Q4 2014 after selling out during the quarter.
  • Tradewinds Capital Management sold 57 Charles River Laboratories shares in Q4 2014, an estimated $3K.
  • Tradewinds Capital Management first reported a position in Charles River Laboratories in Q4 2013 and held it in 4 quarters.
  • Tradewinds Capital Management's Charles River Laboratories position peaked at $3K in Q3 2014.
  • 252 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2014.

Based on Tradewinds Capital Management's 13F filing for Q4 2014, filed 5 Feb 2015.